Issue
Med Sci (Paris)
Volume 28, Number 12, Décembre 2012
L’oncogénomique : chroniques d’un avènement
Page(s) 1116 - 1119
Section Repères
DOI https://doi.org/10.1051/medsci/20122812023
Published online 21 December 2012
  1. Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 2012 ; 12 : 323–334. [CrossRef] [PubMed] [Google Scholar]
  2. Nowell PC. The clonal evolution of tumor cell populations. Science 1976 ; 194 : 23–28. [CrossRef] [PubMed] [Google Scholar]
  3. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009 ; 458 : 719–724. [CrossRef] [PubMed] [Google Scholar]
  4. Schackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009 ; 138 : 822–829. [CrossRef] [PubMed] [Google Scholar]
  5. Reynaud C, Billaud M. La théorie de l’équilibre ponctué : un bond en avant dans la compréhension du cancer. Med/Sci (Paris) 2011 ; 27 : 921–924. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregional sequencing. N Engl J Med 2012 ; 366 : 883–892. [CrossRef] [PubMed] [Google Scholar]
  7. Brahimi-Horn MC, Bellot G, Pouysségur J. Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev 2011 ; 21 : 67–72. [CrossRef] [PubMed] [Google Scholar]
  8. Sonveaux P, Végran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008 ; 118 : 339–342. [Google Scholar]
  9. Maley CC, Galipeau PC, Finley JC, et al. Genetic clonal diversity predicts progression to oesophageal adenocarcinoma. Nat Genet 2006 ; 38 : 468–473. [CrossRef] [PubMed] [Google Scholar]
  10. Park SY, Gönen M, Kim HJ, et al. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest 2010 ; 120 : 636–644. [CrossRef] [PubMed] [Google Scholar]
  11. Greaves M, Maley CC. Clonal evolution in cancer. Nature 2012 ; 481 : 306–313. [CrossRef] [PubMed] [Google Scholar]
  12. Billaud M, Santoro M. Is co-option a prevailing mechanism during cancer progression?. Cancer Res 2011 ; 71 : 6572–6575. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.